WH, J., L, Z., R, G., K, R., H, T., RSP, H., . . . BA, M. (2024). The Molecular, Immunologic, and Clinicodemographic Landscape of MYC-Amplified Advanced Prostate Cancer. Clinical genitourinary cancer, 22(1), e163. https://doi.org/10.1016/j.clgc.2023.10.008
Chicago Style (17th ed.) CitationWH, Jin, et al. "The Molecular, Immunologic, and Clinicodemographic Landscape of MYC-Amplified Advanced Prostate Cancer." Clinical Genitourinary Cancer 22, no. 1 (2024): e163. https://doi.org/10.1016/j.clgc.2023.10.008.
MLA (9th ed.) CitationWH, Jin, et al. "The Molecular, Immunologic, and Clinicodemographic Landscape of MYC-Amplified Advanced Prostate Cancer." Clinical Genitourinary Cancer, vol. 22, no. 1, 2024, p. e163, https://doi.org/10.1016/j.clgc.2023.10.008.